Pubblicazioni Scientifiche

Dermatologia

10 feb 2025

Successful response of upadacitinib in different clinical phenotypes

Successful response of upadacitinib

10 feb 2025

Trends in cutaneous melanoma mortality and incidence in European Union 15+

Cutaneous melanoma (CM) is the leading cause of skin cancer mortality

10 feb 2025

Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis

Abrocitinib is a JAK-1 inhibitor approved for the treatment of moderate-to-severe atopic dermatitis (AD

10 feb 2025

Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata

ALLEGRO-LT is an ongoing, long-term

24 gen 2025

Characterization of different clinical presentation of Merkel cell carcinomas

Recent studies analyzed the impact of Merkel cell polyomavirus (MCPyV) on the prognosis of Merkel cell carcinoma (MCC) patients

24 gen 2025

European S2k guidelines for hidradenitis suppurativa/acne inversa part 2

This second part of the S2k guidelines is an update of the 2015 S1 European guidelines

15 gen 2025

Efficacy of Alexandrite Laser in the Treatment of Pigmented Actinic Keratoses

Pigmented actinic keratoses (PAKs), a pigmented variant of actinic keratosis

15 gen 2025

Reply to incidence of nonmelanoma skin cancer in patients with vitiligo

Reply to ‘incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream’

15 gen 2025

Systematic review of biologic use for psoriasis in HIV-positive individuals

Psoriasis is a chronic, inflammatory systemic condition mediated by T-lymphocyte activation

04 dic 2024

Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata

Ritlecitinib and baricitinib are recently approved systemic treatments for severe alopecia areata (AA)

04 dic 2024

A prospective Real-Life Multicenter Study of Tildrakizumab

A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis

04 dic 2024

Approved systemic drugs needed for dermatosis like alopecia areata

Approved systemic drugs needed for dermatosis

19 nov 2024

A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis

Janus kinase inhibitors (JAKinibs) have the potential to dramatically alter the landscape of atopic dermatitis

19 nov 2024

Validation of a Dermatoscopy-Based Algorithm for the Diagnosis of Acral Melanoma

Diagnosis of acral melanocytic lesions can be challenging

19 nov 2024

Management of human epidermal growth factor receptor inhibitors-related acneiform rash

There is a need for unified guidance in the management of acneiform rash

24 ott 2024

Prediction of melanoma metastasis using dermatoscopy deep features

Machine learning algorithms, and especially convolutional neural networks

24 ott 2024

Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata

Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp

24 ott 2024

Predictors and mechanisms of self-stigma in five chronic skin diseases

People with skin disease suffer due to disease-related physical symptoms

02 ott 2024

Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas

A subset of patients affected by cutaneous squamous cell carcinoma

02 ott 2024

Acute generalized exanthematous pustulosis

Acute generalized exanthematous pustulosis (AGEP) is a rare